A report by the inspector general of the Department of Health and Human Services, Daniel R. Levinson, assails the FDA for failing to ensure the health of patients in clinical trials. According to the report, the FDA could not accurately determine how many trials were being conducted, audited less than 1% of all testing sites and, when an audit found problems, supervisors downgraded the findings...